Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea flag South Korea · Delayed Price · Currency is KRW
28,450
-200 (-0.70%)
Last updated: Jul 22, 2025
-0.70%
Market Cap1.48T
Revenue (ttm)141.00B
Net Income (ttm)-1.69B
Shares Out50.74M
EPS (ttm)-33.58
PE Ration/a
Forward PE169.31
Dividendn/a
Ex-Dividend Daten/a
Volume338,984
Average Volume352,125
Open28,600
Previous Close28,650
Day's Range28,250 - 29,800
52-Week Range24,000 - 52,000
Beta0.78
RSI63.95
Earnings DateAug 14, 2025

About Hanall Biopharma

Hanall Biopharma Co., Ltd., a pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally. The company offers prescription drugs and over-the-counter products for the treatment of diarrhea, prostatic hyperplasia, androgenetic alopecia, chronic renal failure, hypoparathyroidism, vitamin D-resistant rickets, osteomalacia, osteoporosis, prostate cancer, toxic liver disease, chronic hepatitis, liver cirrhosis, male pattern baldness, functional dyspepsia, diabetes, bacterial infections, peripheral vascul... [Read more]

Sector Healthcare
Founded 1973
Employees 304
Stock Exchange Korea Stock Exchange
Ticker Symbol 009420
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.